Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma ...

On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma ...

Below is Validea's guru fundamental report for ARCELLX INC (ACLX). Of the 22 guru strategies we follow, ACLX rates highest using our P/B Growth Investor model based on the published strategy of ...

In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Arcellx Inc (ACLX – Research Report). The company’s shares closed yesterday at $82.27. Pick the ...

Below is a chart showing TTI's trailing twelve month trading history, with the $5 strike highlighted in orange: And Arcellx Inc (Symbol: ACLX) options are showing a volume of 3,325 contracts thus ...

Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Arcellx Inc (ACLX – Research Report) today and set a price target of $122.00. The company’s shares closed last Friday at $84.55.

Arcellx (NASDAQ:ACLX – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a research note issued to investors on Monday,Benzinga reports.

ACLX opened at $75.43 on Thursday. The company has a market capitalization of $4.08 billion, a PE ratio of -106.24 and a beta of 0.25. The business has a 50-day moving average of $89.10 and a 200 ...

In the last three months, 14 analysts have published ratings on Arcellx ACLX, offering a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Is Arcellx, Inc. (ACLX) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.